XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $135,000 | -23.7% | 55,145 | +26.4% | 0.00% | – |
| Q2 2021 | $177,000 | -76.3% | 43,611 | -73.7% | 0.00% | – |
| Q1 2021 | $747,000 | -8.7% | 165,842 | -0.2% | 0.00% | – |
| Q4 2020 | $818,000 | +19.6% | 166,153 | +44.0% | 0.00% | – |
| Q3 2020 | $684,000 | +150.5% | 115,347 | +12.2% | 0.00% | – |
| Q2 2020 | $273,000 | +40.0% | 102,834 | +2.9% | 0.00% | – |
| Q1 2020 | $195,000 | -66.8% | 99,976 | +19.9% | 0.00% | – |
| Q4 2019 | $588,000 | -22.0% | 83,352 | +8.7% | 0.00% | – |
| Q3 2019 | $754,000 | -78.4% | 76,704 | -74.8% | 0.00% | -100.0% |
| Q2 2019 | $3,486,000 | +17.6% | 304,774 | +3.2% | 0.00% | 0.0% |
| Q1 2019 | $2,965,000 | +774.6% | 295,283 | +1380.8% | 0.00% | – |
| Q4 2018 | $339,000 | +29.4% | 19,941 | +33.7% | 0.00% | – |
| Q3 2018 | $262,000 | – | 14,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |